Page 92 - 2020_01-Haematologica-web

B. Nowlan et al.
Expression of CD27 on murine hematopoi-
etic stem and progenitor cells. Immunity.
2000;12(2):193-199.
16. Benz C, Copley MR, Kent DG, et al.
Hematopoietic stem cell subtypes expand differentially during development and dis- play distinct lymphopoietic programs. Cell Stem Cell. 2012;10(3):273-283.
17. Kent DG, Copley MR, Benz C, et al. Prospective isolation and molecular charac- terization of hematopoietic stem cells with durable self-renewal potential. Blood. 2009;113(25):6342-6350.
18. Fares I, Chagraoui J, Lehnertz B, et al. EPCR expression marks UM171-expanded CD34(+) cord blood stem cells. Blood. 2017;129(25):3344-3351.
19. Maykel J, Liu JH, Li H, et al. NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl): a model for stromal cell-tumor cell interaction for human colon cancer. Dig Dis Sci. 2014;59(6):1169-1179.
20. Shultz LD, Lyons BL, Burzenski LM, et al. Human lymphoid and myeloid cell develop- ment in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174(10):6477-6489.
21. Holzapfel BM, Wagner F, Thibaudeau L, Levesque JP, Hutmacher DW. Concise review: humanized models of tumor immunology in the 21st century: conver- gence of cancer research and tissue engineer- ing. Stem Cells. 2015;33(6):1696-1704.
22. Ren G, Esposito M, Kang Y. Bone metastasis and the metastatic niche. J Mol Med (Berl). 2015;93(11):1203-1212.
23. Winkler IG, Barbier V, Nowlan B, et al. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat Med. 2012;18(11):1651-1657.
24. Cook MM, Futrega K, Osiecki M, et al. Micromarrows--three-dimensional cocul- ture of hematopoietic stem cells and mes- enchymal stromal cells. Tissue Eng Part C Methods. 2012;18(5):319-328.
25. Franco C, Britto K, Wong E, et al. Discoidin domain receptor 1 on bone marrow–derived cells promotes macrophage accumulation during atherogenesis. Circ Res. 2009;105 (11):1141-1148.
26. Pietras EM, Reynaud D, Kang YA, et al. Functionally distinct subsets of lineage- biased multipotent progenitors control blood production in normal and regenera- tive conditions. Cell Stem Cell. 2015;17(1):35-46.
27. Knudsen KJ, Rehn M, Hasemann MS, et al.
ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation. Genes Dev. 2015;29(18): 1915-1929.
28. Boles KS, Stepp SE, Bennett M, Kumar V, Mathew PA. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol Rev. 2001;181:234-249.
29. Vaidya SV, Mathew PA. Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells. Immunol Lett. 2006;105(2):180-184.
30. Pinho S, Lacombe J, Hanoun M, et al. PDGFRalpha and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J Exp Med. 2013;210(7):1351- 1367.
31. Qing Y, Lin Y, Gerson SL. An intrinsic BM hematopoietic niche occupancy defect of HSC in scid mice facilitates exogenous HSC engraftment. Blood. 2012;119(7): 1768-1771.
32. Verbiest T, Finnon R, Brown N, et al. NOD Scid gamma mice are permissive to allo- geneic HSC transplantation without prior conditioning. Int J Mol Sci. 2016; 17(11).
33. Katano I, Ito R, Eto T, Aiso S, Ito M. Immunodeficient NOD-scid IL- 2Rgamma(null) mice do not display T and B cell leakiness. Exp Anim. 2011;60(2):181-186.
34. Bosma MJ, Carroll AM. The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol. 1991;9:323-350.
35. Winkler IG, Bendall LJ, Forristal CE, et al. B- lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overex- pression of the anti-apoptotic protein Bcl2. Haematologica. 2013;98(3):325-333.
36. Holmes C, Stanford WL. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells. 2007;25(6):1339-1347.
37. Morikawa S, Mabuchi Y, Kubota Y, et al. Prospective identification, isolation, and sys- temic transplantation of multipotent mes- enchymal stem cells in murine bone mar- row. J Exp Med. 2009;206(11):2483-2496.
38. Xiao Q, Zeng L, Zhang Z, et al. Sca-1+ pro- genitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler Thromb Vasc Biol. 2006;26 (10):2244-2251.
39. Cahill EF, Tobin LM, Carty F, Mahon BP, English K. Jagged-1 is required for the expan- sion of CD4+ CD25+ FoxP3+ regulatory T
cells and tolerogenic dendritic cells by murine mesenchymal stromal cells. Stem Cell Res Ther. 2015;6(1):19.
40. Ooi YY, Rahmat Z, Jose S, Ramasamy R, Vidyadaran S. Immunophenotype and dif- ferentiation capacity of bone marrow- derived mesenchymal stem cells from CBA/Ca, ICR and Balb/c mice. World J Stem Cells. 2013;5(1):34-42.
41. Peister A, Mellad JA, Larson BL, et al. Adult stem cells from bone marrow (MSCs) isolat- ed from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004;103(5):1662-1668.
42. Morcos MNF, Schoedel KB, Hoppe A, et al. SCA-1 expression level identifies quiescent hematopoietic stem and progenitor cells. Stem Cell Reports. 2017;8(6):1472-1478.
43. Bonyadi M, Waldman SD, Liu D, et al. Mesenchymal progenitor self-renewal defi- ciency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci U S A. 2003;100(10):5840-5845.
44. Xiao P, Sandhow L, Heshmati Y, et al. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice. Blood Adv. 2018;2(12):1480-1494.
45. Passaro D, Di Tullio A, Abarrategi A, et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell. 2017;32(3):324-341.e6.
46. Coughlan AM, Harmon C, Whelan S, et al. Myeloid engraftment in humanized mice: impact of granulocyte-colony stimulating factor treatment and transgenic mouse strain. Stem Cells Dev. 2016;25(7):530-541.
47. Karimzadeh A, Scarfone VM, Varady E, et al. The CD11a and endothelial protein C receptor marker combination simplifies and improves the purification of mouse hematopoietic stem cells. Stem Cells Transl Med. 2018;7(6):468-476.
48. Holzapfel BM, Hutmacher DW, Nowlan B, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-114.
49. Martine LC, Holzapfel BM, McGovern JA, et al. Engineering a humanized bone organ model in mice to study bone metastases. Nat Protoc. 2017;12(4):639-663.
50. Nowlan B, Futrega K, Brunck ME, et al. HIF- 1alpha-stabilizing agent FG-4497 rescues human CD34+ cell mobilization in response to G-CSF in immunodeficient mice. Exp Hematol. 2017;52:50-55.e56.
82
haematologica | 2020; 105(1)